Key Trends and Insights into the Hematopoietic Stem Cell Transplantation Market: Growth Rate and Opportunities to 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the hematopoietic stem cell transplantation market grown over the years?
The market size for hematopoietic stem cell transplantation has seen strong growth in recent years. The market is projected to grow from $4.68 billion in 2024 to $5.12 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. The growth experienced in the historical period can be traced back to advancements in transplantation methods, limited indicators and donor sources, improvements in preparation procedures, the advent of allogeneic transplants, and regulatory landmarks.
What Is the forecasted market size and growth rate for the hematopoietic stem cell transplantation market?
A swift escalation is anticipated in the size of the hematopoietic stem cell transplantation market in the subsequent years, as it is projected to reach a worth of “$7.73 billion in 2029 with a compound annual growth rate (CAGR) of 10.9%. This surge in the prediction period can be credited to a multitude of factors such as expansion of treatment indications, diversification of donor sources, the implementation of personalized medicine and genomics, changes in regulatory aspects and guidelines, and widening of market access and availability. The upcoming trends in the forecast period encompass advancements in transplant procedures, extended indications, budding cellular therapies, diversity in donor sources and the precision medicine approach.
Get your hematopoietic stem cell transplantation market report here!
What are the major factors driving growth in the hematopoietic stem cell transplantation market?
The surge in instances of blood cancer is anticipated to drive the growth of the hematopoietic stem cell transplantation market. Blood cancers are a category of malignancies that disrupt the genesis and functionality of blood cells which include three primary types: leukemia, lymphoma, and myeloma. Hematopoietic stem cell transplantation, which replaces malignant-killed stem cells and marrow cells, is a frequent treatment for blood cancer. The new stem cells relocate to the bone marrow and commence the production of new blood cells. Consequently, these elements stimulate the growth of the hematopoietic stem cell transplantation market. For instance, a report from Blood Cancer UK, a UK-based charity in August 2022, noted that blood cancer is identified in 41,000 cases annually – thus making it the sixth most common cancer in the UK. Throughout their lifetime, blood cancer affects one in 16 men and one in 22 women, which will account to around 250,000 people affected in the UK in 2022. Additionally, over 500 children below the age of 15 are impacted by blood cancer each year – 400 suffer from pediatric leukemia and 100 from lymphoma. Because of this rising incidence of blood cancer, the hematopoietic stem cell transplantation market is gaining momentum.
What key areas define the segmentation of the global hematopoietic stem cell transplantation Market?
The hematopoietic stem cell transplantation market covered in this report is segmented –
1) By Type: Allogeneic, Autologous
2) By Indication: Leukemia, Lymphatic Disorder, Myeloma, Other Non-Malignant Disorders
3) By Application: Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, Cord Blood Transplant
4) By End User: Hospital Pharmacy, Retail Pharmacy, Specialty Clinics
Subsegments:
1) By Allogeneic: Matched Related Donor Transplantation, Matched Unrelated Donor Transplantation, Cord Blood Transplantation
2) By Autologous: Peripheral Blood Stem Cell Transplantation, Bone Marrow Stem Cell Transplantation
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10445&type=smp
What are the top market players propelling the growth of the hematopoietic stem cell transplantation industry?
Major companies operating in the hematopoietic stem cell transplantation market include Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd.
What are the key trends shaping the future of the hematopoietic stem cell transplantation market?
A key emerging trend in the hematopoietic stem cell transplantation market involves the gaining popularity of product approvals. To maintain their lead in the market, many leading companies in this area are securing approvals for their products. For example, in April 2022, Priothera Ltd., a late-stage biotech firm based in Ireland, was granted clearance for an investigational new drug (IND) by the United States Food and Drug Administration (FDA). This approval allows the start of a Phase IIb/III study using mocravimod in allogeneic hematopoietic stem cell transplants (HSCT) for patients suffering from acute myeloid leukemia (AML). Also known as KRP203, mocravimod is a synthetic modulator of the sphingosine 1-phosphate receptor (S1PR). Its safety, tolerability, and efficacy have been investigated in Phase I and II trials as a unique experimental treatment for several autoimmune diseases.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10445
What regions are dominating the hematopoietic stem cell transplantation market growth?
North America was the largest region in the hematopoietic stem cell transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Blood Glucose Meters Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report
Patient Blood Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
Blood Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
